Cellectar Biosciences (CLRB) Current Assets (2010 - 2026)
Cellectar Biosciences (CLRB) reported Current Assets of $34.88 million for Q2 2026, up 176.4% from $12.62 million a year earlier.
Powered by 
Analysis
Cellectar Biosciences (CLRB) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Cellectar Biosciences posted Current Assets of $14.04 million, down 42.1% from FY2024.
- Current Assets has a five-year compound annual growth rate of -24.7% (FY2020 to FY2025).
- By year, Current Assets came in at $24.25 million in FY2024 (+132.0%), $10.45 million in FY2023 (-49.1%), $20.53 million in FY2022 (-43.9%) and $36.57 million in FY2021 (-36.9%).
- The Q2 2026 figure ranks as the highest quarterly Current Assets since Q3 2024.
- Year over year, Current Assets gained in three of the last seven quarters, with growth averaging 23.4%.
- The high point for year-over-year Current Assets in five years was Q2 2024 (growth of 397.5%); the low point was Q2 2023 (a decline of 77.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Cellectar Biosciences | 22.38 Mn | 22.38 Mn | - | 34.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.88 Mn |
| Dec 31, 2025 | 14.04 Mn |
| Sep 30, 2025 | 13.62 Mn |
| Jun 30, 2025 | 12.62 Mn |
| Mar 31, 2025 | 14.89 Mn |
| Dec 31, 2024 | 24.25 Mn |
| Sep 30, 2024 | 35.90 Mn |
| Jun 30, 2024 | 27.91 Mn |
| Mar 31, 2024 | 41.37 Mn |
| Dec 31, 2023 | 10.45 Mn |
| Sep 30, 2023 | 20.11 Mn |
| Jun 30, 2023 | 5.61 Mn |
| Mar 31, 2023 | 13.85 Mn |
| Dec 31, 2022 | 20.53 Mn |
| Sep 30, 2022 | 18.76 Mn |
| Jun 30, 2022 | 25.29 Mn |
| Mar 31, 2022 | 31.39 Mn |
| Dec 31, 2021 | 36.57 Mn |
| Sep 30, 2021 | 41.39 Mn |
| Jun 30, 2021 | 47.12 Mn |
API Access
Cellectar Biosciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CLRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CLRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CLRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();